https://newsletter.glp1studio.com/p/minnesota-could-make-your-glp-1-prescriptionGLP-1 Studioen2026-09-26T17:00:00+00:00Minnesota could make your GLP-1 prescription harder to tracehttps://newsletter.glp1studio.com/p/why-analysts-think-lilly-could-keepGLP-1 Studioen2026-09-26T17:00:00+00:00Why analysts think Lilly could keep its obesity drug lead even as Novo regroups